SLC35A3 Gene Arthrogryposis Mental Retardation and Seizures Genetic Test
Test Name: SLC35A3 Gene Arthrogryposis Mental Retardation and Seizures Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Osteology Dermatology Immunology Disorders
Doctor: Dermatologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for SLC35A3 Gene Arthrogryposis, Mental Retardation, and Seizures NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC35A3 Gene Arthrogryposis, Mental Retardation, and Seizures NGS Genetic DNA Test gene SLC35A3
Test Details
The SLC35A3 gene is associated with a genetic condition known as Arthrogryposis, Mental Retardation, and Seizures (AMRS). This condition is characterized by multiple joint contractures (arthrogryposis), intellectual disability (mental retardation), and seizures.
NGS (Next-Generation Sequencing) genetic testing refers to a type of genetic testing that uses high-throughput sequencing technologies to analyze multiple genes simultaneously. This approach allows for the rapid and cost-effective analysis of large gene panels or even the entire exome (all protein-coding genes in the genome).
In the context of AMRS, NGS genetic testing can be used to identify mutations or variants in the SLC35A3 gene. By sequencing this gene, clinicians can determine if there are any alterations in the DNA sequence that may be responsible for the development of the condition.
This type of genetic testing can provide valuable information for diagnosis, prognosis, and genetic counseling for individuals and families affected by AMRS. It can help confirm a suspected diagnosis, guide appropriate medical management, and provide information about the likelihood of passing the condition on to future generations.
Test Name | SLC35A3 Gene Arthrogryposis mental retardation and seizures Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Osteology Dermatology Immunology Disorders |
Doctor | Dermatologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for SLC35A3 Gene Arthrogryposis, mental retardation, and seizures NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC35A3 Gene Arthrogryposis, mental retardation, and seizures NGS Genetic DNA Test gene SLC35A3 |
Test Details |
The SLC35A3 gene is associated with a genetic condition known as Arthrogryposis, Mental Retardation, and Seizures (AMRS). This condition is characterized by multiple joint contractures (arthrogryposis), intellectual disability (mental retardation), and seizures. NGS (Next-Generation Sequencing) genetic testing refers to a type of genetic testing that uses high-throughput sequencing technologies to analyze multiple genes simultaneously. This approach allows for the rapid and cost-effective analysis of large gene panels or even the entire exome (all protein-coding genes in the genome). In the context of AMRS, NGS genetic testing can be used to identify mutations or variants in the SLC35A3 gene. By sequencing this gene, clinicians can determine if there are any alterations in the DNA sequence that may be responsible for the development of the condition. This type of genetic testing can provide valuable information for diagnosis, prognosis, and genetic counseling for individuals and families affected by AMRS. It can help confirm a suspected diagnosis, guide appropriate medical management, and provide information about the likelihood of passing the condition on to future generations. |